Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

174.39 +0.33 (+0.19%)
Official Closing Price Updated: 7:00 PM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,254,445
Open 173.59
Bid (Size) 171.22 (1)
Ask (Size) 175.00 (3)
Prev. Close 174.06
Today's Range 172.19 - 174.71
52wk Range 144.80 - 201.92
Shares Outstanding 473,944,193
Dividend Yield 0.86%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference
From Zoetis Inc.
Via Business Wire
Zoetis Named a Top Company for DE&I by Fair360 (Formerly DiversityInc.)
From Zoetis Inc.
Via Business Wire

Performance

YTD
-11.28%
-11.28%
1 Month
+19.04%
+19.04%
3 Month
-6.52%
-6.52%
6 Month
-0.95%
-0.95%
1 Year
-2.86%
-2.86%

More News

Read More
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
Via InvestorPlace
Topics ETFs
Zoetis Earnings Top; Pet Drugmaker Rises
Via Investor's Business Daily
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Via Benzinga
Topics Stocks
Exposures US Equities
4 Oversold Stocks to Buy Right Now
Via The Motley Fool
Elanco Makes A Bullish Move On Its First Quarter Beat; Are Pet Health Stocks Forging A Comeback?
Via Investor's Business Daily
Bragar Eagel & Squire, P.C. Is Investigating Zoetis, and Morgan Stanley and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via NewMediaWire
Exposures Product Safety
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via TheNewswire.com
Exposures Product Safety
ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
From The Rosen Law Firm PA
Via GlobeNewswire
Zoetis (ZTS) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Zoetis Stock Popped by Almost 6% on Thursday
Via The Motley Fool
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
Via Benzinga
Topics Economy
Exposures Interest Rates
ZTS Stock Earnings: Zoetis Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Why Animal Health-Focused Zoetis Shares Are Trading Higher Today
Via Benzinga
Zoetis Announces First Quarter 2024 Results
From Zoetis Inc.
Via Business Wire
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
ZTS LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via NewMediaWire
Exposures Product Safety
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
Via Benzinga
Topics Stocks
Exposures US Equities
ZTS LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via TheNewswire.com
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
From The Rosen Law Firm PA
Via GlobeNewswire
1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.